<DOC>
	<DOCNO>NCT01392378</DOCNO>
	<brief_summary>The purpose study assess immunological response ( measure amount antibody , i.e . protein fight germ ) produce child give 13-valent pneumococcal vaccine ( 13vPnC ) INFANRIX hexa 2 , 3 , 4 12 month age medication prevent fever give day vaccination . Also evaluate safety 13-valent pneumococcal conjugate vaccine ( 13vPnC ) child receive medication prevent fever day vaccination .</brief_summary>
	<brief_title>Study Assessing Effect Medications Prevent Fever Prevenar 13Â®</brief_title>
	<detailed_description />
	<mesh_term>Vaccines</mesh_term>
	<mesh_term>Heptavalent Pneumococcal Conjugate Vaccine</mesh_term>
	<mesh_term>Antipyretics</mesh_term>
	<mesh_term>Acetaminophen</mesh_term>
	<mesh_term>Ibuprofen</mesh_term>
	<criteria>Aged 2 month ( 56 98 day ) time enrollment . Healthy infant determine medical history , physical examination , judgment investigator . Previous vaccination license investigational pneumococcal , diphtheria , tetanus , pertussis , polio , Hib conjugate vaccine . A previous anaphylactic reaction vaccine vaccinerelated component . Allergy contraindication paracetamol ibuprofen administration . Contraindication vaccination pneumococcal conjugate , diphtheria , tetanus , pertussis , polio , Hib , HBV vaccine .</criteria>
	<gender>All</gender>
	<minimum_age>56 Days</minimum_age>
	<maximum_age>98 Days</maximum_age>
	<verification_date>January 2014</verification_date>
	<keyword>Prevenar 13</keyword>
	<keyword>13vPnC</keyword>
	<keyword>Antipyretic medication</keyword>
	<keyword>Healthy subject</keyword>
</DOC>